BRIEF-Eyconis Announces Initiation Of First-In-Human Clinical Trial Of Eyc-0305 In Treatment-Naïve Wet Age-Related Macular Degeneration Patients
Reuters2026/08/18 12:11By:Reuters
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Ascendis Pharma A/S ASND.O:
EYCONIS ANNOUNCES INITIATION OF FIRST-IN-HUMAN CLINICAL TRIAL OF EYC-0305 IN TREATMENT-NAÏVE WET AGE-RELATED MACULAR DEGENERATION PATIENTS
Source text: ID:nGNXc52pRS
Further company coverage: ASND.O
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
BRIEF-Jack Henry & Associates Inc Q4 Operating Margin 21.2%
Reuters•2026/08/18 20:36
MicroStrategy Founder Explains How to Make Money With AI: Is He Right?
BeInCrypto•2026/08/18 20:33
Polar Power: Jim Ahern and Menachem Shalom Named to Bd. >POLA
Dow Jones•2026/08/18 20:33
Crypto prices
More
Bitcoin
BTC
$64,564.67
+0.34%
Ethereum
ETH
$1,912.36
+0.40%
Tether USDt
USDT
$0.9992
+0.01%
USDC
USDC
$0.9999
+0.00%
XRP
XRP
$0.9993
-0.27%
Solana
SOL
$76.84
+1.24%
TRON
TRX
$0.3327
+0.49%
Hyperliquid
HYPE
$58.66
-0.16%
Dogecoin
DOGE
$0.07022
-0.02%
Zcash
ZEC
$508.25
-1.77%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now